Supreme Court Restores Access to Abortion Pill by Mail for Now

The United States Supreme Court has temporarily restored access to the abortion pill mifepristone via mail delivery, blocking a lower court ruling that had imposed restrictions on its distribution.

Legal Background

In 2023, the Food and Drug Administration (FDA) implemented a rule allowing mifepristone to be prescribed via telemedicine and delivered by mail. The state of Louisiana challenged this rule, leading to a ruling by the Fifth Circuit Court of Appeals that reinstated the requirement for in-person consultations to obtain the drug.

Supreme Court's Temporary Stay

On May 4, 2026, Justice Samuel Alito issued an administrative stay, pausing the Fifth Circuit's ruling and allowing the continued distribution of mifepristone through telehealth services and mail delivery. This stay is set to expire on May 11, 2026, providing the Court time to consider the case further.

Implications for Abortion Access

Mifepristone, used in combination with misoprostol, is a widely used method for medication abortions in the United States. The Supreme Court's temporary order maintains access to this method without the need for in-person visits, which is particularly significant in states with restrictive abortion laws.

For more detailed information, refer to the original article on The Washington Post: Supreme Court Restores Access to Abortion Pill by Mail for Now.